» Articles » PMID: 10892805

Tumor Suppressor INK4: Refinement of P16INK4A Structure and Determination of P15INK4B Structure by Comparative Modeling and NMR Data

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2000 Jul 13
PMID 10892805
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Within the tumor suppressor protein INK4 (inhibitor of cyclin-dependent kinase 4) family, p15INK4B is the smallest and the only one whose structure has not been determined previously, probably due to the protein's conformational flexibility and instability. In this work, multidimensional NMR studies were performed on this protein. The first tertiary structure was built by comparative modeling with p16INK4A as the template, followed by restrained energy minimization with NMR constraints (NOE and H-bonds). For this purpose, the solution structure of pl6INK4A, whose quality was also limited by similar problems, was refined with additional NMR experiments conducted on an 800 MHz spectrometer and by structure-based iterative NOE assignments. The nonhelical regions showed major improvement with root-mean-square deviation (RMSD) improved from 1.23 to 0.68 A for backbone heavy atoms. The completion of p15INK4B coupled with refinement of p16INK4A made it possible to compare the structures of the four INK4 members in depth, and to compare the structures of p16INK4A in the free form and in the p16INK4A-CDK6 complex. This is an important step toward a comprehensive understanding of the precise functional roles of each INK4 member.

Citing Articles

High frequency of melanoma in /.

Ran R, Li L, Cheng P, Li H, He H, Chen Y Theranostics. 2024; 14(19):7470-7487.

PMID: 39659584 PMC: 11626935. DOI: 10.7150/thno.97475.


Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers.

Beklen H, Arslan S, Gulfidan G, Turanli B, Ozbek P, Karademir Yilmaz B Front Bioinform. 2022; 1:710591.

PMID: 36303724 PMC: 9581026. DOI: 10.3389/fbinf.2021.710591.


Evolution and folding of repeat proteins.

Galpern E, Marchi J, Mora T, Walczak A, Ferreiro D Proc Natl Acad Sci U S A. 2022; 119(31):e2204131119.

PMID: 35905321 PMC: 9351489. DOI: 10.1073/pnas.2204131119.


Folding and Stability of Ankyrin Repeats Control Biological Protein Function.

Kumar A, Balbach J Biomolecules. 2021; 11(6).

PMID: 34198779 PMC: 8229355. DOI: 10.3390/biom11060840.


Structural insights into the functional diversity of the CDK-cyclin family.

Wood D, Endicott J Open Biol. 2018; 8(9).

PMID: 30185601 PMC: 6170502. DOI: 10.1098/rsob.180112.


References
1.
Hannon G, Beach D . p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994; 371(6494):257-61. DOI: 10.1038/371257a0. View

2.
Guan K, Jenkins C, Li Y, Nichols M, Wu X, OKeefe C . Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 1994; 8(24):2939-52. DOI: 10.1101/gad.8.24.2939. View

3.
Glendening J, Flores J, Walker G, Stone S, Albino A, Fountain J . Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient. Cancer Res. 1995; 55(23):5531-5. View

4.
Sali A, Potterton L, Yuan F, Van Vlijmen H, Karplus M . Evaluation of comparative protein modeling by MODELLER. Proteins. 1995; 23(3):318-26. DOI: 10.1002/prot.340230306. View

5.
Iolascon A, Faienza M, Coppola B, Rosolen A, Basso G, Della Ragione F . Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma. Genes Chromosomes Cancer. 1996; 15(4):217-22. DOI: 10.1002/(SICI)1098-2264(199604)15:4<217::AID-GCC3>3.0.CO;2-4. View